482 related articles for article (PubMed ID: 27738100)
21. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.
Head SA; Shi W; Zhao L; Gorshkov K; Pasunooti K; Chen Y; Deng Z; Li RJ; Shim JS; Tan W; Hartung T; Zhang J; Zhao Y; Colombini M; Liu JO
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7276-85. PubMed ID: 26655341
[TBL] [Abstract][Full Text] [Related]
22. Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC).
Tewari D; Majumdar D; Vallabhaneni S; Bera AK
Sci Rep; 2017 Mar; 7():45184. PubMed ID: 28327594
[TBL] [Abstract][Full Text] [Related]
23. Dominant-negative VDAC1 mutants reveal oligomeric VDAC1 to be the active unit in mitochondria-mediated apoptosis.
Mader A; Abu-Hamad S; Arbel N; Gutiérrez-Aguilar M; Shoshan-Barmatz V
Biochem J; 2010 Jul; 429(1):147-55. PubMed ID: 20420578
[TBL] [Abstract][Full Text] [Related]
24. Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis.
Keinan N; Tyomkin D; Shoshan-Barmatz V
Mol Cell Biol; 2010 Dec; 30(24):5698-709. PubMed ID: 20937774
[TBL] [Abstract][Full Text] [Related]
25. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
Shoshan-Barmatz V; Mizrachi D; Keinan N
Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
[TBL] [Abstract][Full Text] [Related]
26. IP
Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
[TBL] [Abstract][Full Text] [Related]
27. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
28. The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target.
Verma A; Pittala S; Alhozeel B; Shteinfer-Kuzmine A; Ohana E; Gupta R; Chung JH; Shoshan-Barmatz V
Mol Ther; 2022 Feb; 30(2):726-744. PubMed ID: 34217890
[TBL] [Abstract][Full Text] [Related]
29. Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology.
Verma A; Shteinfer-Kuzmine A; Kamenetsky N; Pittala S; Paul A; Nahon Crystal E; Ouro A; Chalifa-Caspi V; Pandey SK; Monsonego A; Vardi N; Knafo S; Shoshan-Barmatz V
Transl Neurodegener; 2022 Dec; 11(1):58. PubMed ID: 36578022
[TBL] [Abstract][Full Text] [Related]
30. VDAC1 cysteine residues: topology and function in channel activity and apoptosis.
Aram L; Geula S; Arbel N; Shoshan-Barmatz V
Biochem J; 2010 Apr; 427(3):445-54. PubMed ID: 20192921
[TBL] [Abstract][Full Text] [Related]
31. VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases.
Shoshan-Barmatz V; Shteinfer-Kuzmine A; Verma A
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114780
[TBL] [Abstract][Full Text] [Related]
32. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial Voltage-Dependent Anion Channel 1-Hexokinase-II Complex-Targeted Strategy for Melanoma Inhibition Using Designed Multiblock Peptide Amphiphiles.
Zhang F; Angelova A; Garamus VM; Angelov B; Tu S; Kong L; Zhang X; Li N; Zou A
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35281-35293. PubMed ID: 34309373
[TBL] [Abstract][Full Text] [Related]
34. Phosphoglycerate mutase 5 aggravates alcoholic liver disease through disrupting VDAC-1-dependent mitochondrial integrity.
Xia T; Yu J; Chen Y; Chang X; Meng M
Int J Med Sci; 2024; 21(4):755-764. PubMed ID: 38464835
[TBL] [Abstract][Full Text] [Related]
35. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
Front Oncol; 2017; 7():154. PubMed ID: 28824871
[TBL] [Abstract][Full Text] [Related]
36. Dysfunction in the mitochondrial Fe-S assembly machinery leads to formation of the chemoresistant truncated VDAC1 isoform without HIF-1α activation.
Ferecatu I; Canal F; Fabbri L; Mazure NM; Bouton C; Golinelli-Cohen MP
PLoS One; 2018; 13(3):e0194782. PubMed ID: 29596470
[TBL] [Abstract][Full Text] [Related]
37. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity.
Arbel N; Shoshan-Barmatz V
J Biol Chem; 2010 Feb; 285(9):6053-62. PubMed ID: 20037155
[TBL] [Abstract][Full Text] [Related]
38. Voltage-Dependent Anion Channel 1(VDAC1) Participates the Apoptosis of the Mitochondrial Dysfunction in Desminopathy.
Li H; Zheng L; Mo Y; Gong Q; Jiang A; Zhao J
PLoS One; 2016; 11(12):e0167908. PubMed ID: 27941998
[TBL] [Abstract][Full Text] [Related]
39. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1.
Singh V; Khalil MI; De Benedetti A
Cell Cycle; 2020 Feb; 19(3):363-375. PubMed ID: 31914854
[TBL] [Abstract][Full Text] [Related]
40. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
Arzoine L; Zilberberg N; Ben-Romano R; Shoshan-Barmatz V
J Biol Chem; 2009 Feb; 284(6):3946-55. PubMed ID: 19049977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
